Is Cencora (COR) overvalued or fairly valued?

MarketChacha shows Cencora's valuation in context — a forward P/E of about 15.3, a price-to-book of about 17.3 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Cencora (COR)?

Cencora last traded at $302.44 (-0.2% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Cencora

COR · NYSE · Healthcare · United States

$302.44-0.2%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:17 PM

Snapshot

TickerCOR

ExchangeNYSE

SectorHealthcare

IndustryMedical Distribution

CountryUnited States

Employees47,000

HeadquartersConshohocken, United States

Market cap$58.8B

P/B17.3

Volume308.29K

Websitewww.cencora.com

Filings tracked0

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Profile as reported by Yahoo Finance.

Who owns it

Insiders4.2%
Institutions95.8%
Public & other0.0%

1,920 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.10.25%
Vanguard Capital Management LLC6.33%
Vanguard Portfolio Management LLC4.93%
State Street Corporation4.72%
Price (T.Rowe) Associates Inc3.76%
FMR, LLC3.44%
T. Rowe Price Investment Management, Inc.3.24%
Geode Capital Management, LLC2.86%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $88.3B · EPS 4.61

Est. earnings growth +20.1%

Next fiscal year

Rev $358.1B · EPS 19.82

Est. earnings growth +11.5%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$244.8252-wk range$377.54

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about COR

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.